Literature DB >> 8427034

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers.

A M Palache1, W E Beyer, M J Sprenger, N Masurel, S de Jonge, A Vardy, B Charpentier, J Noury, W C van Beek, R J Borst.   

Abstract

The dose effect (0, 10, 20 and 60 micrograms) of influenza subunit vaccine on the antibody response was investigated in nursing-home residents and young controls. The vaccine antigens were: A/Taiwan/1/86 (H1N1), A/Sichuan/2/87 (H3N2) and B/Beijing/1/87. For the influenza B antigen, the post-GMT and the 'percentage protective titre' increased significantly both in the young controls and nursing-home residents. No dose effect was observed for the A/Taiwan, and a minor dose effect for A/Sichuan. All vaccine doses were well tolerated by both groups. We conclude from our data that higher vaccine doses may result in a better antibody response against some antigens but not against others. Therefore, in general, increasing the vaccine dose is no adequate method to improve the antibody response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8427034     DOI: 10.1016/0264-410x(93)90333-s

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Evaluation of ready-to-use and multi-dose influenza vaccine formats in large clinic settings.

Authors:  D W Scheifele; D Skowronski; A King; C A LaJeunesse; G L Bjornson; H Parkyn; N Walker; E Stefura
Journal:  Can J Public Health       Date:  2000 Sep-Oct

Review 2.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

3.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

4.  A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.

Authors:  Robert L Atmar; Wendy A Keitel; Thomas R Cate; Flor M Munoz; Fred Ruben; Robert B Couch
Journal:  Vaccine       Date:  2007-05-22       Impact factor: 3.641

5.  Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.

Authors:  W E Beyer; A M Palache; R Kerstens; N Masurel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 6.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

7.  High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.

Authors:  Jack T Stapleton; Nancy Wagner; Rebecca Tuetken; Abbie R Bellamy; Heather Hill; Sonnie Kim; Patricia L Winokur
Journal:  Vaccine       Date:  2020-04-12       Impact factor: 3.641

8.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

9.  Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.

Authors:  Pierre Van Damme; Robert Arnou; Froukje Kafeja; Anne Fiquet; Patrick Richard; Stéphane Thomas; Gilles Meghlaoui; Sandrine Isabelle Samson; Emilio Ledesma
Journal:  BMC Infect Dis       Date:  2010-05-26       Impact factor: 3.090

Review 10.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.